Endocrinologist, Associate Professor, Division of Endocrinology & Metabolism, Departments of Medicine and Obstetrics & Gynaecology
Schulich School of Medicine & Dentistry, Western University and St. Joseph's Health Care London
Division of Endocrinology & Metabolism, Department of Medicine, Department of Obstetrics & Gynaecology, Schulich School of Medicine & Dentistry, Western University
London, Ontario, Canada
Dr. Selina Liu is an Associate Professor in the Division of Endocrinology & Metabolism, Department of Medicine at the Schulich School of Medicine & Dentistry, Western University in London, Ontario Canada. She is also cross-appointed to the Department of Obstetrics & Gynaecology at Western University, and is an Associate Scientist at Lawson Health Research Institute.
Dr. Liu obtained her medical degree at Queen’s University, Kingston (2006), and completed her Internal Medicine residency (2010) and Endocrinology & Metabolism fellowship (2011) at Western University. She was the recipient of the 2011 Schulich Resident Research Career Development program award which supported her MSc Epidemiology & Biostatistics (Clinical Epidemiology) (2014). She also previously completed her MSc Pharmacology & Toxicology (2004) prior to her medical training. Dr. Liu joined the Division of Endocrinology & Metabolism, Department of Medicine as a Clinician-Researcher in 2014.
She is the Medical Director of the Endocrine Pregnancy Clinic of St. Joseph’s Health Care London, which is the regional referral centre in southwest Ontario for endocrine problems in pregnancy. She is also the Co-Director of the St. Joseph’s Hospital Diabetes Clinical Trials Unit and has participated as Site Principal Investigator for both investigator-initiated and pharma-sponsored multicentre clinical trials of new insulins and glucose monitoring systems for diabetes in pregnancy, and of new medications for type 2 diabetes. Other research interests include strategies to improve diabetic retinopathy screening and treatment.
Friday, November 22, 2024
14:15 - 15:30 AT Time
Disclosure(s): Dexcom Canada: Consultant (Ongoing), Grant/Research Support (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); Novo Nordisk Canada Inc.: Grant/Research Support (Terminated); Tandem: Grant/Research Support (Ongoing)